AstraZeneca, Soccer, E-Cigarettes: Intellectual Property

Nov. 25 (Bloomberg) -- AstraZeneca Plc and Ranbaxy Laboratories Ltd. failed to derail a landmark trial in the U.S. accusing the companies of colluding to delay the release of a cheaper version of the top-selling heartburn pill Nexium.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.